FACCHINETTI, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 161
EU - Europa 64
AS - Asia 46
Continente sconosciuto - Info sul continente non disponibili 32
SA - Sud America 4
AF - Africa 1
Totale 308
Nazione #
US - Stati Uniti d'America 155
DE - Germania 32
IT - Italia 25
CN - Cina 13
HK - Hong Kong 13
BD - Bangladesh 7
VN - Vietnam 5
SG - Singapore 4
CL - Cile 3
CA - Canada 2
FR - Francia 2
JM - Giamaica 2
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
GB - Regno Unito 1
HR - Croazia 1
IN - India 1
IQ - Iraq 1
JO - Giordania 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 276
Città #
San Jose 59
Frankfurt am Main 32
New York 19
Ashburn 18
Hong Kong 13
Beijing 12
Hillsboro 6
Milan 6
Los Angeles 4
Santa Clara 4
Buffalo 3
Dallas 3
Rancho Santa Margarita 3
Reston 3
Santiago 3
Bologna 2
Charlotte 2
Florence 2
Hanoi 2
Ho Chi Minh City 2
Phoenix 2
Toronto 2
Algiers 1
Amman 1
Bari 1
Bergamo 1
Bovisio-Masciago 1
Bucyrus 1
Chaguanas 1
Chennai 1
Chicago 1
Duluth 1
Genoa 1
Honolulu 1
Jacksonville 1
Jersey City 1
Kingston 1
Lagrangeville 1
Las Vegas 1
Lincoln Park 1
Lindenhurst 1
London 1
Miami 1
Missoula 1
Najaf 1
Naples 1
Orem 1
Pasadena 1
Philadelphia 1
Rome 1
Sacramento 1
San Francisco 1
San José 1
Sanford 1
Scottsdale 1
Singapore 1
Spanish Town 1
Suba 1
Tashkent 1
Turin 1
Warsaw 1
Zagreb 1
Totale 242
Nome #
Cytoprotective effects of a polyphenol-based extract from humulus lupulus l. against damage induced by respiratory toxicants in airway cells 28
Co-ultramicronized palmitoylethanolamide/luteolin restores the astrocyteoligodendrocyte cross-talk required for myelination via peroxisome proliferator-activated receptor-a in an in vitro model of Alzheimer's disease 16
Looking for a treatment for the early stage of Alzheimer’s disease. Preclinical evidence with co-ultramicronized palmitoylethanolamide and luteolin 15
Investigating the role of oligodendrocytes in a pharmacological model of autism spectrum disorders 14
Astrocyte: an innovative approach for Alzheimer's disease therapy 13
An animal model of Alzheimer disease based on the intrahippocampal injection of amyloid beta-peptide (Abeta) 13
Resilient and vulnerable rats to acute foot shock stress show different glial cell responses: possible rescue of pathological alterations by a single ketamine administration 13
Astrocytes and Alzheimer’s disease: the pharmacological manipulation as promising tool against pathology progression. Evidence from a triple transgenic model of the disease 12
Effect of palmitoylethanolamide in a triple transgenic model of Alzheimer’s disease 12
Ultramicronized palmitoylethanolamide restores astrocyte-neuron metabolic coupling and klotho/fgf21 signaling in a triple-transgenic mouse model of alzheimer's disease 11
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex 10
Astrocyte-neuron interplay in Alzheimer's disease: evidence from an innovative and promising pharmacological manipulation in a triple transgenic model of the disease 10
Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features 10
Effect of palmytoilethanolamide in 3xTg-AD astrocytes as in vitro model of Alzheimer’s disease 9
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 9
Effect of palmitoylethanolamide on astrocyte activity in a triple transgenic model of Alzheimer’s disease 9
Altered waste disposal system in aging and Alzheimer’s disease: focus on astrocytic aquaporin-4 9
Neuroinflammation in Alzheimer's disease: friend or foe? 8
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD 8
Reactive astrogliosis and neuronal impairment: in vitro and in vivo evidence on palmitoylethanolamide effects in a triple transgenic model of Alzheimer’s disease 8
The role of glial cells in neuropsychiatric disorders 8
Astrocyte Function Is Affected by Aging and Not Alzheimer’s Disease: A Preliminary Investigation in Hippocampi of 3xTg-AD Mice 8
Effect of ultramicronized-palmytoilethanolamide on astrocyte dysfunction in a triple transgenic model of Alzheimer’s disease 8
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 8
Co-ultramicronized palmitoylethanolamide/luteolin restores oligodendrocyte homeostasis via peroxisome proliferator-activated receptor-α in an In vitro model of Alzheimer’s disease 8
Alternative targets to fight Alzheimer’s disease. Focus on astrocytes 7
Sorafenib chemosensitization by caryophyllane sesquiterpenes in liver, biliary, and pancreatic cancer cells: the role of STAT3/ABC transporter axis 6
Preparation of rat hippocampal organotypic cultures and application to study amyloid beta-peptide toxicity 5
Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer’s disease: in vitro and in vivo evidence 4
Palmitoylethanolamide and white matter lesions. Evidence for therapeutic implications 4
Ultramicronized palmitoylethanolamide improves learning and memory in a triple transgenic mouse model of Alzheimer's disease through a combination of anti-inflammatory and neuroprotective effects 3
Neuroglia in the autistic brain: evidence from a preclinical model 2
Totale 308
Categoria #
all - tutte 4.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026274 0 0 0 0 0 0 0 95 33 104 14 28
2026/202734 14 19 1 0 0 0 0 0 0 0 0 0
Totale 308